Download video

Mektovi (Binimetinib)

367 views

Garvan Lynch

5 years ago

Mektovi (Binimetinib)

Mektovi (Binimetinib)

Mektovi (Binimetinib)
12:45
Mektovi (Binimetinib)
by Garvan is Almost Human
Dr. Flaherty on the Tolerability of Encorafenib\/Binimetinib in Melanoma
1:02
Dr. Flaherty on the Tolerability of Encorafenib\/Binimetinib in Melanoma
by OncLive
Combination Encorafenib Plus Binimetinib in Patients With Melanoma
0:33
Combination Encorafenib Plus Binimetinib in Patients With Melanoma
by Targeted Oncology
Evaluating Therapy With Encorafenib, Binimetinib, and Ribociclib in Melanoma
4:04
Evaluating Therapy With Encorafenib, Binimetinib, and Ribociclib in Melanoma
by Targeted Oncology
POLARIS: encorafenib\/binimetinib for advanced BRAFV600+ melanoma
0:53
POLARIS: encorafenib\/binimetinib for advanced BRAFV600+ melanoma
by VJOncology
Rationale for MEK\/BRAF Combinations in Melanoma
1:09
Rationale for MEK\/BRAF Combinations in Melanoma
by Targeted Oncology
Mekinist (Trametinib)- unresectable or metastatic melanoma
2:14
Mekinist (Trametinib)- unresectable or metastatic melanoma
by Pharmacy Talk USA
What is Stage IV Melanoma?
20:55
What is Stage IV Melanoma?
by From The Clinic To The Living Room: Melanoma 101
Understanding Melanoma
5:49
Understanding Melanoma
by You and Melanoma
BRAF\/MEK Inhibitors in Metastatic Melanoma
8:47
BRAF\/MEK Inhibitors in Metastatic Melanoma
by OncLive
First-Line Triplet in BRAF+ mCRC
3:25
First-Line Triplet in BRAF+ mCRC
by OncLive
BRAF and MEK Inhibitors in Melanoma: A Clinical Overview
23:07
BRAF and MEK Inhibitors in Melanoma: A Clinical Overview
by AIMatMelanoma
Encorafenib\/binimetinib\/nivolumab combo improves PFS in BRAF-mutant melanoma brain metastases
3:46
Encorafenib\/binimetinib\/nivolumab combo improves PFS in BRAF-mutant melanoma brain metastases
by ecancer
Biotech lesson 3: Braftovi+Mektovi and drug hunting
1:24:27
Biotech lesson 3: Braftovi+Mektovi and drug hunting
by Jennifer Lin
Pembrolizumab + binimetinib in patients with advanced TNBC
1:38
Pembrolizumab + binimetinib in patients with advanced TNBC
by VJOncology
Trametinib (Mekinist) and BRAF V600 Cancer Therapy
10:41
Trametinib (Mekinist) and BRAF V600 Cancer Therapy
by P. J. Blois
Case 2: Long-Term BRAF\/MEK Data in Melanoma
6:44
Case 2: Long-Term BRAF\/MEK Data in Melanoma
by Targeted Oncology
SECOMBIT: treatment sequencing in metastatic melanoma and incidence of brain metastasis
1:42
SECOMBIT: treatment sequencing in metastatic melanoma and incidence of brain metastasis
by VJOncology
Metastatic melanoma: long-term benefits of a targeted therapies combination
3:25
Metastatic melanoma: long-term benefits of a targeted therapies combination
by Gustave Roussy
New \& Emerging Treatments for Advanced Melanoma
19:52
New \& Emerging Treatments for Advanced Melanoma
by AIMatMelanoma
Genomic drivers of resistance to anti-BCMA immunotherapies in multiple myeloma
2:01
Genomic drivers of resistance to anti-BCMA immunotherapies in multiple myeloma
by VJHemOnc – Video Journal of Hematology \& HemOnc